MC2 Therapeutics A/S

Public limited companyCVR 29526346HørsholmActive

MC2 Therapeutics A/S is a public limited company, based in Hørsholm, active in manufacture of pharmaceutical preparations, founded in 2006. Equity was negative at the end of 2025 (−DKK 224.6m). The company made a loss in both 2024 and 2025, most recently DKK 7.8m. Gross profit is higher than that of 75% of the companies in the industry in the database.

PDF report Compare

Key figures · financial year 2025

Gross profitDKK 43.2m+2,848.9% vs. 2024

Net profit−DKK 7.8m+85.4% vs. 2024

Equity−DKK 224.6m−2.7% vs. 2024

Employees8latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

Gross profit rose 2,849% (2024 → 2025), to DKK 43.2m.
The loss got smaller: from DKK 53m to DKK 7.8m (2024 → 2025).

Employees

2 fewer employees than a year earlier: 8 (08/2026) against 10 (08/2025).

Management and owners, last 24 months

New in management: Trine Ahlgreen (director, 26/05/2025).
Stepped down: Jesper Jørn Lange (director, 26/05/2025).

Registrations, last 24 months

01/01/2025: Industry changed to Manufacture of pharmaceutical preparations (212000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

EquityNet profit

Financial figures for MC2 Therapeutics A/S
	2020	2021	2022	2023	2024	2025	Change
Revenue	not stated	not stated	not stated	not stated	not stated	not stated	–
Gross profit	15,938	27,734	−74,372	577	1,466	43,234	+2,848.9%
Operating profit (EBIT)	987	1,452	−105,280	−33,549	−31,862	14,759	+146.3%
Profit before tax	−87,070	−25,223	−111,604	−47,797	−60,411	−7,785	+87.1%
Net profit	−86,941	−25,223	−101,415	−41,869	−53,022	−7,766	+85.4%
Total assets	36,145	51,603	83,664	57,642	110,012	86,350	−21.5%
Equity	13,930	−21,098	−122,733	−164,635	−218,603	−224,615	−2.7%
Liabilities	12,733	72,700	206,398	222,277	328,615	307,964	−6.3%
Cash and cash equivalents	7,805	1,466	8,628	15,997	16,269	18,906	+16.2%
Average number of employees	–	19	30	29	26	20	−23.1%

Source: annual reports filed with the Danish Business Authority (XBRL). Group figures; change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

Compare with the industry (59 companies)

Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

Negative equity
Equity was −DKK 224.6m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years

Annual reports for MC2 Therapeutics A/S
Financial year	Period	Published	Figures for	Documents
2025	01/01/2025 – 31/12/2025	02/07/2026	The group	PDF not statedXBRL
2024	01/01/2024 – 31/12/2024	30/06/2025	The group	PDF XBRL
2023	01/01/2023 – 31/12/2023	08/07/2024	The group	PDF XBRL
2022	01/01/2022 – 31/12/2022	17/07/2023	The group	PDF XBRL
2021	01/01/2021 – 31/12/2021	30/06/2022	The company	PDF XBRL
2020	01/01/2020 – 31/12/2020	01/07/2021	The company	PDF XBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR

Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 43.2mNo. 15 of 57

Better than 75% of the companies in the industry

Equity−DKK 224.6mNo. 59 of 59

Better than 0% of the companies in the industry

Number of employees8No. 21 of 59

Better than 66% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form

Rank among similar companies
Group	Gross profit	Equity
Companies with fewer than 20 employees69,967 companies in the comparison	No. 614of 69,742 Better than 99%	No. 69,957of 69,964 Better than 0%
Same industry and fewer than 20 employees37 companies in the comparison	No. 3of 36 Better than 94%	No. 37of 37 Better than 0%
Companies that are between 15 and 29 years old24,910 companies in the comparison	No. 1,661of 24,791 Better than 93%	No. 24,903of 24,909 Better than 0%
All companies of type A/S18,025 companies in the comparison	No. 3,315of 17,786 Better than 81%	No. 18,012of 18,024 Better than 0%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations

Gross profit

MC2 Therapeutics A/SDKK 43.2m
Novo Nordisk A/SDKK 250.3bn
H. Lundbeck A/SDKK 20.4bn

Net profit

MC2 Therapeutics A/S−DKK 7.8m
Novo Nordisk A/SDKK 102.4bn
H. Lundbeck A/SDKK 3.2bn

Equity

MC2 Therapeutics A/S−DKK 224.6m
Novo Nordisk A/SDKK 194bn
H. Lundbeck A/SDKK 24.9bn

Employees

MC2 Therapeutics A/S8
Novo Nordisk A/S27,279
H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register

Owners

Mc2 Holding ApS15%
Selskabet af 4. april 2023 ApS33.33%
Alsmark Invest II ApS33.33%

MC2 Therapeutics A/S

Management

5 active registrations

Executive management

Executive management at MC2 Therapeutics A/S
Name	Role	Appointed
Trine Ahlgreen	Director	26/05/2025

Board of directors

Board of directors at MC2 Therapeutics A/S
Name	Role	Appointed
Mads Jørgen Nøhr Clausen	Chair of the board	20/06/2017
Anders Dahlgaard Hove	Board member	20/06/2017
Tomas Dahl Mikkelsen	Board member	24/01/2023
John Sørensen Haurum	Board member	26/10/2023

Auditor: Cedra Godkendt Revisionsaktieselskab
Founders: Jesper Jørn Lange

Former management (6)

Former management at MC2 Therapeutics A/S
Name	Role	Appointed	Resigned
Steen Sindet-Pedersen	Director	04/05/2006	19/09/2006
Anette Merete Nøhr Clausen	Director	19/09/2006	27/11/2006
Jesper Jørn Lange	Director	27/11/2006	26/05/2025
Jesper Jørn Lange	Board member	20/06/2017	24/01/2023
Mette Vagner Johannesen	Board member	20/06/2017	08/11/2022
Paul Louis Berns	Board member	20/06/2017	14/09/2020

Signing rule: Selskabet tegnes af en direktør eller af den samlede bestyrelse

Address and production units

1 active production units

Agern Alle 24
2970 Hørsholm

Rudersdal Municipality · Postcode 2970

Production units
Production unit	Address	Industry	Employees	P number
MC2 Therapeutics A/S	Agern Alle 24-26, 2970 Hørsholm	Manufacture of pharmaceutical preparations	8	1012239072

Purpose

Selskabets formål er at udøve innovations-, forsknings- og udviklingsaktivitet indenfor medicinal- og sundheds-branchen, og at drive handelsvirksomhed dermed, samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed, herunder udvikling, køb og salg af immaterielle rettigheder eller medicinske produkter samt at besidde ejerandele i virksomheder, som udøver lignende aktiviteter.

The purpose is quoted from the register in Danish.

Changes year by year

83 registered events

22015

92016

112017

112018

102019

22020

12021

22022

82023

12024

42025

12026

20261 changeaccounts 1

02/07AccountsAnnual report for 2025 published

20254 changesaccounts 1 · management 2 · industry 1

30/06AccountsAnnual report for 2024 published
26/05ManagementTrine Ahlgreen appointed director
26/05ManagementJesper Jørn Lange stepped down as director
01/01IndustryIndustry changed to Manufacture of pharmaceutical preparations (212000)

20241 changeaccounts 1

08/07AccountsAnnual report for 2023 published

20238 changesownership 4 · management 3 · accounts 1

27/12OwnershipAlsmark Invest II ApS registered as owner (33.33%)
27/12OwnershipNovember S.á.r.l. is no longer registered as owner
26/10ManagementJohn Sørensen Haurum appointed board member
17/07AccountsAnnual report for 2022 published
11/07OwnershipSelskabet af 4. april 2023 ApS registered as owner (33.33%)
11/07OwnershipHOLDINGSELSKABET J.S.R. AF 1.11.83 ApS is no longer registered as owner
24/01ManagementTomas Dahl Mikkelsen appointed board member
24/01ManagementJesper Jørn Lange stepped down as board member

20222 changesmanagement 1 · accounts 1

08/11ManagementMette Vagner Johannesen stepped down as board member
30/06AccountsAnnual report for 2021 published

20211 changeaccounts 1

01/07AccountsAnnual report for 2020 published

20202 changescapital 1 · management 1

31/12CapitalShare capital changed from 6,561,607 DKK to 6,611,484 DKK
14/09ManagementPaul Louis Berns stepped down as board member

201910 changesownership 5 · capital 5

10/09OwnershipHOLDINGSELSKABET J.S.R. AF 1.11.83 ApS registered as owner (33.33%)
10/09OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS is no longer registered as owner
01/09OwnershipFÆLLES INVEST 2 A/S is no longer registered as owner
28/08CapitalShare capital changed from 6,511,730 DKK to 6,561,607 DKK
23/08CapitalShare capital changed from 6,446,608 DKK to 6,511,730 DKK
07/05CapitalShare capital changed from 6,371,218 DKK to 6,446,608 DKK
07/05OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS registered as owner (33.33%)
06/05OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS is no longer registered as owner
01/05CapitalShare capital changed from 6,291,895 DKK to 6,371,218 DKK
11/01CapitalShare capital changed from 6,216,505 DKK to 6,291,895 DKK

201811 changescapital 5 · ownership 6

31/12CapitalShare capital changed from 6,120,262 DKK to 6,216,505 DKK
04/10CapitalShare capital changed from 5,818,702 DKK to 6,120,262 DKK
18/06CapitalShare capital changed from 5,441,752 DKK to 5,818,702 DKK
18/06OwnershipMC2 HOLDING ApS registered as owner (15%)
18/06OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS registered as owner (15%)
18/06OwnershipFÆLLES INVEST 2 A/S registered as owner (10%)
17/06OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS is no longer registered as owner
17/06OwnershipFÆLLES INVEST 2 A/S is no longer registered as owner
17/06OwnershipMC2 HOLDING ApS is no longer registered as owner
19/01CapitalShare capital changed from 5,431,901 DKK to 5,441,752 DKK
18/01CapitalShare capital changed from 5,152,958 DKK to 5,431,901 DKK

201711 changescapital 2 · ownership 3 · name 1 · management 5

08/12CapitalShare capital changed from 5,118,100 DKK to 5,152,958 DKK
01/09CapitalShare capital changed from 4,741,150 DKK to 5,118,100 DKK
01/09OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS registered as owner (10%)
31/08OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS is no longer registered as owner
28/06OwnershipFÆLLES INVEST 2 A/S registered as owner (15%)
20/06NameName changed from MC2 Therapeutics ApS to MC2 Therapeutics A/S
20/06ManagementMads Jørgen Nøhr Clausen appointed chair of the board
20/06ManagementAnders Dahlgaard Hove appointed board member
20/06ManagementPaul Louis Berns appointed board member
20/06ManagementJesper Jørn Lange appointed board member
20/06ManagementMette Vagner Johannesen appointed board member

20169 changesownership 7 · name 1 · capital 1

02/12OwnershipNovember S.á.r.l. registered as owner (33.33%)
02/12OwnershipALSMARK INVEST II ApS is no longer registered as owner
01/12NameName changed from MC2 BIOTEK ApS to MC2 Therapeutics ApS
01/12CapitalShare capital changed from 436,420 DKK to 4,741,150 DKK
01/12OwnershipMC2 HOLDING ApS registered as owner (20%)
01/12OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS registered as owner (20%)
01/12OwnershipLANC ApS is no longer registered as owner
30/11OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS is no longer registered as owner
30/11OwnershipMC2 HOLDING ApS is no longer registered as owner

20152 changescapital 1 · address 1

14/12CapitalShare capital changed from 411,541 DKK to 436,420 DKK
09/04AddressMoved to Agern Alle 24-26, 2970 Hørsholm

20146 changescapital 2 · ownership 4

08/12CapitalShare capital changed from 396,463 DKK to 411,541 DKK
08/12OwnershipINVESTERINGSSELSKABET AF 30.4.1992 ApS registered as owner (15%)
08/12OwnershipLANC ApS registered as owner (5%)
08/12OwnershipALSMARK INVEST II ApS registered as owner (33.33%)
08/12OwnershipMC2 HOLDING ApS registered as owner (25%)
27/06CapitalShare capital changed from 381,385 DKK to 396,463 DKK

20131 changecapital 1

01/07CapitalShare capital changed from 132,850 DKK to 381,385 DKK

20111 changemerger 1

06/07MergerMerger registered in CVR

20101 changeaddress 1

26/03AddressMoved to Bøge Alle 5, 2970 Hørsholm

20091 changeaddress 1

02/07AddressMoved to Tuborg Havnevej 19, 2900 Hellerup

20081 changeindustry 1

01/01IndustryIndustry changed to Andre personlige serviceydelser i.a.n. (960900)

200610 changesmanagement 5 · address 1 · name 1 · industry 1 · capital 1 · founded 1

27/11ManagementJesper Jørn Lange appointed director
27/11ManagementAnette Merete Nøhr Clausen stepped down as director
22/11AddressMoved to Tuborg Havnevej 18, 2900 Hellerup
12/10NameName changed from BIOTECH AF 4. MAJ 2006 ApS to MC2 BIOTEK ApS
19/09ManagementAnette Merete Nøhr Clausen appointed director
19/09ManagementSteen Sindet-Pedersen stepped down as director
01/09IndustryIndustry changed to Anden servicevirksomhed i øvrigt (930500)
01/09CapitalShare capital changed from 125,000 DKK to 132,850 DKK
04/05FoundedRegistered as BIOTECH AF 4. MAJ 2006 ApS
04/05ManagementSteen Sindet-Pedersen appointed director

Related companies

Same industry in Rudersdal

Alk-abelló A/S1,009 employees
Scanpharm A/S40 employees
Synact Pharma ApS7 employees
Allarity Therapeutics Europe ApS4 employees
Breye Therapeutics ApS3 employees

See all →

Same people in management

Danfoss A/Svia Mads Jørgen Nøhr Clausen
Fjordstjernen Boliger og Sundhedscenter A/Svia Mette Vagner Johannesen
Xo Care A/Svia Mette Vagner Johannesen
Adcendo ApSvia John Sørensen Haurum
Saniona A/Svia John Sørensen Haurum
Mequ A/Svia Mette Vagner Johannesen

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVR Report a correction